Twist Bioscience Corp vs State Street PDR S&P Retail ETF — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while State Street PDR S&P Retail ETF trades at $88.47. Which is the better fit depends on your goals.
| TWST | XRT | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $102.88 | $90.88 |
52-Week Low | $24.16 | $77.28 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →